Long-term prognostic impact of cardiovascular comorbidities in patients with prostate cancer receiving androgen deprivation therapy: A population-based competing risk analysis.
Sign Up to like & getrecommendations! Published in 2023 at "International journal of cancer"
DOI: 10.1002/ijc.34557
Abstract: Our study investigated how adverse cardiovascular outcomes are impacted by cardiovascular comorbidities in patients with prostate cancer treated by androgen deprivation therapy (ADT). Using prospective, population-based data, all Hong Kong patients with prostate cancer who… read more here.
Keywords: comorbidities patients; prostate cancer; cardiovascular comorbidities; androgen deprivation ... See more keywords
The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE)
Sign Up to like & getrecommendations! Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12086
Abstract: Abstract Whereas younger female patients were diagnosed with idiopathic pulmonary arterial hypertension (IPAH) in 1980s, it is now frequently encountered in elderly patients with cardiovascular comorbidities (CVCs) associated with increased risk for left heart disease.… read more here.
Keywords: arterial hypertension; idiopathic pulmonary; hypertension; disease ... See more keywords
Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis
Sign Up to like & getrecommendations! Published in 2020 at "Rheumatology International"
DOI: 10.1007/s00296-020-04573-w
Abstract: The aim of this study was to generate practical recommendations to assist rheumatologists and dermatologists in the management of cardiovascular (CV) comorbidities in patients with moderate-to-severe psoriasis (MS-PSO) and psoriatic arthritis (PsA). A two-round Delphi… read more here.
Keywords: cardiovascular comorbidities; comorbidities patients; management; management cardiovascular ... See more keywords
Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS
Sign Up to like & getrecommendations! Published in 2025 at "Advances in Therapy"
DOI: 10.1007/s12325-025-03180-0
Abstract: Patients diagnosed with pulmonary arterial hypertension (PAH) often present with risk factors associated with cardiovascular disease, including diabetes mellitus (DM), hypertension (HTN), and obesity. The 2022 ESC/ERS pulmonary hypertension treatment guidelines recommend initial monotherapy with… read more here.
Keywords: combination therapy; combination; cardiovascular comorbidities; patients pah ... See more keywords
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
Sign Up to like & getrecommendations! Published in 2024 at "Dermatology and Therapy"
DOI: 10.1007/s13555-024-01152-w
Abstract: Psoriasis is now considered a systemic disease, and several comorbidities have been described such as cardiovascular diseases, neurologic and psychiatric disorders, chronic inflammatory bowel disease, psoriatic arthritis, etc. Regarding cardiovascular comorbidities, major adverse cardiovascular events… read more here.
Keywords: cardiovascular comorbidities; psoriasis molecular; molecular target; target therapies ... See more keywords
Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.
Sign Up to like & getrecommendations! Published in 2018 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2018.05.002
Abstract: Myelodysplastic syndromes (MDS) and associated diseases, like chronic myelomonocytic leukemias (CMML), are heterogeneous, clonal disorders affecting the hematopoietic stem cells. They are characterized by dysplasia and a propensity to evolve toward acute myeloid leukemia. Systemic… read more here.
Keywords: myelodysplastic syndromes; cardiovascular comorbidities; autoimmune manifestations; chronic myelomonocytic ... See more keywords
Cerebral cavernous malformations: Prevalence of cardiovascular comorbidities and allergic diseases compared to the normal population
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Neurology"
DOI: 10.1111/ene.14833
Abstract: To determine the prevalence of cardiovascular comorbidities and allergic diseases in patients with cavernous malformations of the central nervous system compared to the normal population. read more here.
Keywords: cardiovascular comorbidities; allergic diseases; compared normal; comorbidities allergic ... See more keywords
Combination of Antiplatelet Therapy in Psoriatic Diseases With Cardiovascular Comorbidities: A Thromboinflammatory Perspective in the Era of Biologic Therapies
Sign Up to like & getrecommendations! Published in 2025 at "Experimental Dermatology"
DOI: 10.1111/exd.70177
Abstract: Cardiovascular disease (CVD) remains the leading cause of death worldwide and represents the most significant comorbidity associated with psoriatic disease. Despite significant advancements in biologic therapies for psoriasis skin lesions, the lack of specific recommendations… read more here.
Keywords: therapy psoriatic; cardiovascular comorbidities; combination antiplatelet; biologic therapies ... See more keywords
OP0178 CARDIOVASCULAR COMORBIDITIES HAVE A DELETERIOUS IMPACT ON KNEE OSTEOARTHRITIS PROGNOSIS AT 5 YEARS: DATA FROM THE PROSPECTIVE KHOALA COHORT
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.3500
Abstract: Background The long-term effect of comorbidities on progression of structural changes in osteoarthritis (OA) remains poorly understood. Patients with knee OA have been reported to be at increased risk of several comorbidities including cardiovascular diseases… read more here.
Keywords: cardiovascular comorbidities; hip; cohort; knee ... See more keywords
Optimising the management of cardiovascular comorbidities in NAFLD patients: it’s time to (re-) act!
Sign Up to like & getrecommendations! Published in 2022 at "Gut"
DOI: 10.1136/gutjnl-2021-326662
Abstract: With great interest, we have read the recent article by Simon et al, reporting a significant association between nonalcoholic fatty liver disease (NAFLD) and incident major adverse cardiovascular events. The authors found that patients with… read more here.
Keywords: cardiovascular comorbidities; management cardiovascular; mortality; disease ... See more keywords
Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke
Sign Up to like & getrecommendations! Published in 2017 at "Stroke"
DOI: 10.1161/strokeaha.117.018251
Abstract: Background and Purpose— There remains uncertainty as whether newly diagnosed atrial fibrillation (AF) after ischemic stroke reflects underlying heart disease and represents an increased risk of cardioembolic stroke, or whether it is triggered by neurogenic… read more here.
Keywords: atrial fibrillation; ischemic stroke; cardiovascular comorbidities; newly diagnosed ... See more keywords